SCHEMBL4980016

SCHEMBL4980016

CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CCC(=O)CC(=O)CC(=O)O

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HMGCR P04035 5/20 0.68
▸ SLCO1B1 Q9Y6L6 4/20 0.68
▸ ABCB11 O95342 3/20 0.68
▸ HDAC1 Q13547 2/20 0.68
▸ HDAC2 Q92769 2/20 0.68
▸ HDAC6 Q9UBN7 2/20 0.68
▸ NR1I2 O75469 1/20 0.68
▸ RHOC P08134 1/20 0.68
▸ CYP3A4 P08684 1/20 0.68
▸ THRB P10828 1/20 0.68
▸ NR1H4 Q96RI1 1/20 0.68
▸ ABCG2 Q9UNQ0 1/20 0.68
▸ ABCC3 O15438 2/20 0.64
▸ ABCC4 O15439 2/20 0.64
▸ SLCO1B3 Q9NPD5 2/20 0.64
▸ ABCB1 P08183 1/20 0.60
▸ ABCC2 Q92887 1/20 0.60
▸ PDE6D O43924 4/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5150889 0.98 HMGCR (0.70) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL14131058 0.94 HMGCR (0.65) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL6318546 0.90 HMGCR (0.60) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL14131031 0.89 HMGCR (0.59) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL28541933 0.88 HMGCR (0.78) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL28541931 0.88 HMGCR (0.78) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL13766356 0.87 HMGCR (0.66) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL6138508 0.86 HMGCR (0.81) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL1032 0.86 HMGCR (0.81) HMGCRSLCO1B1ABCB11HDAC1HDAC2
SCHEMBL12073345 0.86 HMGCR (0.72) HMGCRSLCO1B1ABCB11HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7399773-B2 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid and phenylamide WARNER-LAMBERT COMPANY (US) 2008-07-15 — — US disclosed
US-7371855-B2 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide WARNER-LAMBERT COMPANY (US) 2008-05-13 — — US disclosed
US-7361771-B2 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide WARNER-LAMBERT COMPANY (US) 2008-04-22 — — US disclosed
EP-1534704-B1 PROCESS FOR PREPARING 5-(4-FLUOROPHENYL)-1-¬2-((2R,4R)-4-HYDROXY -6-OXO-TETRAHYDRO-PYRAN-2-YL)ETHYL|-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE WARNER LAMBERT CO (US) 2007-08-01 — — EP disclosed
EP-1534704-B1 PROCESS FOR PREPARING 5-(4-FLUOROPHENYL)-1-¬2-((2R,4R)-4-HYDROXY -6-OXO-TETRAHYDRO-PYRAN-2-YL)ETHYL|-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE WARNER LAMBERT CO (US) 2007-08-01 — — EP disclosed
EP-1353917-B1 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-(2-((2R, 4R)-4-HYDROXY -6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL)-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE WARNER LAMBERT CO (US) 2007-03-28 — — EP disclosed
US-7183408-B2 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide WARNER-LAMBERT COMPANY, LLC (US) 2007-02-27 — — US disclosed
US-20070032663-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide BUTLER DONALD E 2007-02-08 — — US disclosed
US-20070032664-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide BUTLER DONALD E 2007-02-08 — — US disclosed
US-20070032662-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrole-3-carboxylic acid and phenylamide BUTLER DONALD E 2007-02-08 — — US disclosed
US-20040220254-A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide NELSON JADE D (US) 2004-11-04 — — US disclosed
US-6777560-B2 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide WARNER-LAMBERT COMPANY 2004-08-17 — — US disclosed
US-20040068121-A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide NELSON JADE D (US) 2004-04-08 — — US disclosed
WO-2004014896-A1 PROCESS FOR PREPARING 5-(4-FLUOROPHENYL)-1-[2-((2R,4R)-4-HYDROXY -6-OXO-TETRAHYDRO-PYRAN-2-YL)ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE WARNER-LAMBERT COMPANY LLC (US) 2004-02-19 — — WO disclosed
EP-1353917-A2 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-(2-((2R, 4R)-4-HYDROXY -6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL)-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE WARNER-LAMBERT COMPANY (US) 2003-10-22 — — EP disclosed
US-20030195353-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide BUTLER DONALD EUGENE (US) 2003-10-16 — — US disclosed
US-6545153-B1 Anticholesterol agents; antilipemic agents WARNER-LAMBERT COMPANY 2003-04-08 — — US disclosed
US-6476235-B2 CHEMICAL INTERMEDIATE; ANTICHOLESTEROL AGENTS, ANTILIPEMIC AGENTS WARNER-LAMBERT COMPANY 2002-11-05 — — US disclosed
US-20020133026-A1 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-[2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE BUTLER DONALD EUGENE (US) 2002-09-19 — — US disclosed
WO-2002055519-A2 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-[2-((2R, 4R)-4-HYDROXY -6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE WARNER LAMBERT CO (US) 2002-07-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032662-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrole-3-carboxylic acid and phenylamide PCCA, PAH, HPD HMGCR 620/4885SLCO1B1 3814/4885ABCB11 4805/4885
US-20030195353-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide PCCA, PAH, HPD HMGCR 837/4885SLCO1B1 3776/4885ABCB11 4792/4885
US-20020133026-A1 NOVEL PROCESS FOR THE SYNTHESIS OF 5-(4-FLUOROPHENYL)-1-[2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-PYRAN-2-YL)-ETHYL]-2-ISOPROPYL-4-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID PHENYLAMIDE PCCA, PAH, HPD HMGCR 995/4885SLCO1B1 3793/4885ABCB11 4789/4885
US-20070032664-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide PAH, PCCA, HPD HMGCR 1030/4885SLCO1B1 4058/4885ABCB11 4824/4885
US-20040220254-A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl) ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide HMGCR, ORAI1, RYR2 HMGCR 1/4885SLCO1B1 640/4885ABCB11 3480/4885
US-20040068121-A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide HMGCR, ORAI1, RYR2 HMGCR 1/4885SLCO1B1 724/4885ABCB11 3453/4885
US-20070032663-A1 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide PAH, PCCA, HPD HMGCR 1030/4885SLCO1B1 4058/4885ABCB11 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback